Aemetis (NASDAQ:AMTX) Stock Rating Upgraded by StockNews.com

Aemetis (NASDAQ:AMTX) was upgraded by equities research analysts at StockNews.com to a “sell” rating in a research report issued on Wednesday.

Several other equities analysts also recently weighed in on AMTX. HC Wainwright reissued a “buy” rating and set a $28.00 price objective on shares of Aemetis in a research note on Monday. Ascendiant Capital Markets reduced their price target on shares of Aemetis from $20.00 to $19.00 and set a “buy” rating on the stock in a research report on Tuesday, September 3rd. One analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $12.95.

Aemetis Trading Up 8.7 %

Shares of AMTX stock opened at $2.86 on Wednesday. The company has a market cap of $142.24 million, a price-to-earnings ratio of -1.27 and a beta of 1.35. Aemetis has a 12-month low of $2.10 and a 12-month high of $7.03. The stock has a 50 day simple moving average of $3.29 and a 200-day simple moving average of $2.99.

Aemetis (NASDAQ:AMTX) last issued its quarterly earnings data on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.47) by $0.09. The company had revenue of $81.44 million for the quarter, compared to analyst estimates of $77.79 million. During the same quarter in the prior year, the firm earned ($0.59) earnings per share. On average, equities analysts forecast that Aemetis will post -2.02 earnings per share for the current fiscal year.

Institutional Trading of Aemetis

Several hedge funds have recently made changes to their positions in AMTX. FMR LLC increased its holdings in shares of Aemetis by 68.2% during the third quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock valued at $52,000 after purchasing an additional 9,137 shares during the period. Hutchinson Capital Management CA purchased a new position in shares of Aemetis in the second quarter worth approximately $70,000. Barclays PLC boosted its position in shares of Aemetis by 274.6% in the third quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock worth $109,000 after buying an additional 34,816 shares during the period. Rhumbline Advisers increased its holdings in shares of Aemetis by 2,837.1% in the 2nd quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock valued at $157,000 after purchasing an additional 50,528 shares during the period. Finally, Geode Capital Management LLC boosted its stake in shares of Aemetis by 7.7% during the 3rd quarter. Geode Capital Management LLC now owns 924,293 shares of the specialty chemicals company’s stock valued at $2,126,000 after buying an additional 66,031 shares during the period. Institutional investors own 27.02% of the company’s stock.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.